Novel Molecular Methods in Soft Tissue Sarcomas: From Diagnostics to Theragnostics

Area of Science:

• Oncology
• Pathology
• Genetics

Background:

• Soft tissue sarcomas (STSs) represent a heterogeneous category of malignant neoplasms.
• These tumors arise from mesenchymal tissues, encompassing a wide spectrum of histological subtypes.
• Understanding STS diversity is crucial for effective treatment strategies.

Purpose of the Study:

• To provide a comprehensive overview of soft tissue sarcoma (STS) classification and characteristics.
• To identify key molecular alterations and potential therapeutic vulnerabilities in various STS subtypes.
• To highlight recent advancements in the diagnosis and management of STSs.

Main Methods:

• Review of current literature on STS epidemiology, pathology, and molecular genetics.
• Analysis of diagnostic criteria and classification systems for STSs.
• Examination of preclinical and clinical data on targeted therapies and immunotherapies for STSs.

Main Results:

• STSs exhibit significant heterogeneity, with over 50 distinct subtypes identified.
• Specific genetic mutations and gene expression profiles are associated with distinct STS subtypes.
• Emerging targeted therapies show promise in preclinical models and early clinical trials.

Conclusions:

• Accurate subtyping of STSs is essential for personalized treatment approaches.
• Molecular profiling is increasingly important for identifying actionable targets in STS.
• Continued research into the biology of STSs is vital for improving patient outcomes.